scholarly journals Updates in the pathophysiological mechanisms of Parkinson’s disease: Emerging role of bone marrow mesenchymal stem cells

2016 ◽  
Vol 8 (3) ◽  
pp. 106 ◽  
Author(s):  
Hanaa H Ahmed ◽  
Ahmed M Salem ◽  
Hazem M Atta ◽  
Emad F Eskandar ◽  
Abdel Razik H Farrag ◽  
...  
2019 ◽  
Author(s):  
Bárbara Pinheiro ◽  
Sandra I. Anjo ◽  
Bruno Manadas ◽  
Jorge D. Da Silva ◽  
Ana Marote ◽  
...  

PLoS ONE ◽  
2014 ◽  
Vol 9 (8) ◽  
pp. e105118 ◽  
Author(s):  
Xiaofeng Yin ◽  
Huamin Xu ◽  
Yunxia Jiang ◽  
Wenshuai Deng ◽  
Zeyu Wu ◽  
...  

2021 ◽  
Author(s):  
Dhruv Mahendru ◽  
Ashish Jain ◽  
Seema Bansal ◽  
Deepti Malik ◽  
Neha Dhir ◽  
...  

Aim: The aim of the study was to evaluate the neuroprotective effect of bone marrow stem cell secretome in the 6-hydroxydopamine (6-OHDA) model of Parkinson's disease. Materials & methods: Secretome prepared from mesenchymal stem cells of 3-month-old rats was injected daily for 7 days between days 7 and 14 after 6-OHDA administration. After 14 days, various neurobehavioral parameters were conducted. These behavioral parameters were further correlated with biochemical and molecular findings. Results & conclusion: Impaired neurobehavioral parameters and increased inflammatory, oxidative stress and apoptotic markers in the 6-OHDA group were significantly modulated by secretome-treated rats. In conclusion, mesenchymal stem cells-derived secretome could be further explored for the management of Parkinson's disease.


2017 ◽  
Vol 5 (9) ◽  
pp. 450-459
Author(s):  
WalaaAMEl Nahrawy ◽  
◽  
FatmaAAbu Zahra ◽  
RabhaEAEL Dab ◽  
◽  
...  

Sign in / Sign up

Export Citation Format

Share Document